Literature DB >> 9732346

Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.

C A Findlay1, J F Macdonald, A M Wallace, N Geddes, M D Donaldson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9732346      PMCID： PMC1113875          DOI： 10.1136/bmj.317.7160.739

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Corticosteroids and adrenal suppression. Characterising and avoiding the problem.

Authors:  E L Helfer; L I Rose
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 2.  The pharmacokinetics of corticosteroid agents.

Authors:  E J Begg; H C Atkinson; N Gianarakis
Journal:  Med J Aust       Date:  1987-01-05       Impact factor: 7.738

3.  Iatrogenic Cushing's syndrome due to nasal betamethasone: a problem not to be sniffed at!

Authors:  C M Nutting; S R Page
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

4.  Adrenal suppression and cushingoid changes secondary to dexamethasone nose drops.

Authors:  W M Heroman; D E Bybee; J Cardin; J W Bass; R E Johnsonbaugh
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

5.  Cushing's syndrome due to the abuse of betamethasone nasal drops.

Authors:  D J Stevens
Journal:  J Laryngol Otol       Date:  1988-03       Impact factor: 1.469

6.  Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops.

Authors:  C E Daman Willems; R Dinwiddie; D B Grant; R P Rivers; M Zahir
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183
  6 in total
  11 in total

1.  Severe adrenal suppression by steroid nasal drops.

Authors:  G Gill; A Swift; A Jones; D Strain; P Weston
Journal:  J R Soc Med       Date:  2001-07       Impact factor: 5.344

2.  Intranasal corticosteroids in allergic rhinitis. Paper did not include all data on adverse effects.

Authors:  D Paddon
Journal:  BMJ       Date:  1999-05-15

3.  Cushing's syndrome induced by betamethasone nose drops. In rhinological disease betamethasone should be regarded as systemic corticosteroid.

Authors:  J J Homer; T G Gazis
Journal:  BMJ       Date:  1999-05-15

Review 4.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Linear growth arrest without weight gain due to overuse of topical clobetasol.

Authors:  Zahra Razavi; Milad Sanginabadi
Journal:  Oman Med J       Date:  2014-11

6.  Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.

Authors:  Maria Francesca Messina; Mariella Valenzise; Salvatore Aversa; Teresa Arrigo; Filippo De Luca
Journal:  BMJ Case Rep       Date:  2009-05-08

7.  Cushing syndrome after bilateral lensectomy.

Authors:  Karin Sofia Scherrer; Marcus Weitz; Johannes Eisenack; Béatrice Truffer; Daniel Konrad
Journal:  Eur J Pediatr       Date:  2014-12-24       Impact factor: 3.183

Review 8.  Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.

Authors:  B J Lipworth; C M Jackson
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 9.  Comparison of medical and surgical treatment of nasal polyposis.

Authors:  Glenis K Scadding
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

10.  Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy.

Authors:  A Scutelnicu; A M Panaitescu; A M Ciobanu; N Gica; R Botezatu; G Peltecu; M L Gheorghiu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.